EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2026 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2026 Earnings Call Transcript May 6, 2026EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 8,296,375 | $106,940,274 | +6% | 2.73% |
| 2. | Cormorant Asset Management Bihua Chen | 8,265,000 | $106,535,850 | 5.35% | |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 3,300,000 | $42,537,000 | -30% | 0.07% |
| 4. | Paradigm Biocapital Advisors Senai Asefaw | 3,142,437 | $40,506,013 | -15% | 0.83% |
| 5. | Commodore Capital Egen Atkinson And Michael Kramarz | 2,825,000 | $36,414,250 | 2.11% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.15 | 1,500 | $19,723.80 | 100,665 | 2026-03-16 | Filing | |
| $5.99 | 5,000 | $29,950.00 | 36,500 | 2025-05-19 | Filing | |
| $5.81 | 5,000 | $29,050.00 | 31,500 | 2025-05-16 | Filing | |
| $5.47 | 5,000 | $27,350.00 | 26,500 | 2025-05-15 | Filing | |
| $5.42 | 5,000 | $27,100.00 | 21,500 | 2025-05-14 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-04-17 | Filing | |
| $17.87 | 2,438 | $43,571.69 | 0 | 2026-03-04 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-02-17 | Filing | |
| $17.10 | 42,544 | $727,319.46 | 0 | 2026-01-05 | Filing | |
| $15.70 | 60,000 | $942,240.00 | 8,265,000 | 2025-12-04 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,177,337 | $92,515,874 | 0% | |
| 2. | 5,669,589 | $73,081,003 | 0.12% | |
| 3. | 5,048,598 | $65,076,424 | 0.02% | |
| 4. | 3,601,168 | $46,419,056 | 0.02% | |
| 5. | 3,559,569 | $45,882,844 | 0% |